Entyvio

Takeda Pharmaceuticals America, Inc.🇺🇸 United States

FDA Page

Effective Date: Apr 29, 2026
Approval ID: 6e94621c-1a95-4af9-98d1-52b9e6f1949c
Products: 3 registered
Version: 26

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use ENTYVIO safely and effectively. See full prescribing information for ENTYVIO. ENTYVIO (vedolizumab) for injection, for intravenous use ENTYVIO (vedolizumab) injection, for subcutaneous use ENTYVIO PEN (vedolizumab) injection, for subcutaneous use Initial U.S. Approval: 2014

Quick Stats

Total Products3

Labelers2

Label Sections42

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.